3 results about "Brain dysfunction" patented technology

The application discloses an information processing method and device for brain dysfunction auxiliary analysis, equipment and medium, relates to the technical field of data analysis, and comprises the following steps: acquiring initial functional magnetic resonance data, and preprocessing the initial functional magnetic resonance data to obtain target functional magnetic resonance data; generating feature data of each brain region based on the target functional magnetic resonance data, and determining the target importance of each brain region and the target correlation between each brain region based on the feature data; determining the target spatial coding of each brain region based on the comparison result of each target correlation and a preset threshold, and constructing a target graph structure coding based on the target importance, the target correlation and the target spatial coding of each brain region; generating enhanced features based on each target graph structure coding and each feature data, determining a classification result based on the enhanced features, and generating and outputting a brain dysfunction analysis result by using the classification result. The application can improve the accuracy of functional magnetic resonance data classification and meet the medical image analysis demand.

The present invention relates to a brain dysfunction and seizure detector monitor and system, and a method of detecting brain dysfunction and / or seizure of a subject. Preferably, the present invention also includes one or more seizure detection algorithms. The analysis method is specifically optimized to amplify abnormal brain activity and minimize normal background activity yielding a seizure index directly related to the current presence of ictal activity in the signal. Additionally, a seizure probability index based on historical values of the aforementioned seizure index, is derived for diagnostic purposes. The seizure probability index quantifies the probability that the patient has exhibited abnormal brain activity since the beginning of the recording. These indexes can be used in the context of emergency and / or clinical situations to assess the status and well-being of a patient's brain, or can be used to automatically administer treatment to stop the seizure before clinical signs appear.

A composition for preventing and / or improving brain dysfunction, especially Alzheimer's disease is provided. The composition includes dihydromyricetin or salts thereof, L-theanine, taurine, and cerebroside, which can enhance the intestinal stability and bioavailability of dihydromyricetin and prevent and improve brain dysfunction through multiple mechanisms such as anti-inflammation, inhibition of DNA methylation, elimination of hematoma, and removal of Aβ. In addition, the composition can be used in combination with monoclonal antibody drugs to reduce adverse reactions such as cerebral edema and cerebral hemorrhage that may occur during the treatment of Alzheimer's disease.